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University of Illinois at Chicago, Chicago, IllinoisABSTACT The structural mechanics of tropomyosin are essential determinants of its afﬁnity and positioning on F-actin. Thus,
tissue-speciﬁc differences among tropomyosin isoforms may inﬂuence both access of actin-binding proteins along the actin
ﬁlaments and the cooperativity of actin-myosin interactions. Here, 40 nm long smooth and striated muscle tropomyosin mole-
cules were rotary-shadowed and compared by means of electron microscopy. Electron microscopy shows that striated muscle
tropomyosin primarily consists of single molecules or paired molecules linked end-to-end. In contrast, smooth muscle tropomy-
osin is more a mixture of varying-length chains of end-to-end polymers. Both isoforms are characterized by gradually bending
molecular contours that lack obvious signs of kinking. The ﬂexural stiffness of the tropomyosins was quantiﬁed and evaluated.
The persistence lengths along the shaft of rotary-shadowed smooth and striated muscle tropomyosin molecules are equivalent
to each other (~100 nm) and to values obtained from molecular-dynamics simulations of the tropomyosins; however, the
persistence length surrounding the end-to-end linkage is almost twofold higher for smooth compared to cardiac muscle
tropomyosin. The tendency of smooth muscle tropomyosin to form semi-rigid polymers with continuous and undampened rigidity
may compensate for the lack of troponin-based structural support in smooth muscles and ensure positional ﬁdelity on smooth
muscle thin ﬁlaments.INTRODUCTIONThe actin-binding protein tropomyosin is found in virtually
all cells (1,2). The 40 nm long coiled-coil molecule, referred
to here as a monomer, links together end-to-end to form
polymeric strands that associate longitudinally along the
sides of actin filaments (3–5). The presence of the tropomy-
osin strands on actin-containing thin filaments has two major
effects. Tropomyosin strengthens the filaments by increasing
their mechanical stiffness (6,7) while at the same time it acts
as a variable filter to regulate the binding of other actin-
binding proteins onto the filament surface (3–5,8–10).
Even though tropomyosin is highly conserved, over 40
tropomyosin isoforms occur in mammalian cells, which
represent the product of multiple genes and alternative tran-
scriptional splicing (1,2). Of all the different isoforms char-
acterized to date, cardiac and skeletal muscle tropomyosins
are the best understood in terms of structure and function.
In concert with troponin, and responding to varying Ca2þ
concentration, striated muscle tropomyosin alternatively
blocks or opens myosin-binding sites on actin to inhibit or
activate myosin crossbridge cycling and consequently relax
or promote muscle contractility (3–5,8–12). Although it is
less well recognized, the role played by tropomyosin in
troponin-free smooth muscle filaments is no less significant,
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Thus, at a very fundamental level, tropomyosin is respon-
sible for the cooperativity of the myosin-actin interaction
and the effectiveness of on-off switching of muscle contrac-
tions (13,14). Hence, despite the absence of troponin in
smooth muscle, smooth muscle tropomyosin still participates
as a regulator of muscle activity. Although smooth muscles
are mainly governed by myosin phosphorylation and not
Ca2þ binding to troponin (14,15), the cooperativity con-
ferred on actomyosin interactions by tropomyosin presum-
ably decreases the intracellular Ca2þ concentration range
and the extent of myosin phosphorylation over which
smooth muscle activation and relaxation occurs, and thus
the efficacy of the overall on-off switching process. It
follows that smooth muscle (and presumably nonmuscle)
tropomyosin is more than just a passive device designed to
strengthen actin filaments and/or protect them from depoly-
merizing and remodeling factors.
F-actin only binds tropomyosin effectively once tropomy-
osin is linked together end-to-end; in contrast, the association
of F-actin with individual tropomyosin molecules is
extremely weak (16). In skeletal and cardiac muscle, tropo-
myosin is further stabilized on actin filaments by being
buttressed by the troponin T subunit of troponin (TnT). In
fact, the N-terminal tail of TnT (TnT1) associates with and
lies over the tropomyosin end-to-end links. Thus this domain
is likely to strengthen striated muscle tropomyosin end-to-
end connectivity, thereby reducing the tendency of indi-
vidual tropomyosin molecules to dissociate from F-actin (17).doi: 10.1016/j.bpj.2010.05.004
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forms show sequence variation. Sequence specialization in
smooth muscle tropomyosin, for example, may lead to
tighter end-to-end linkages, thus compensating for the lack
of TnT-linked stabilization in the smooth muscles (18).
Moreover, the enhanced end-to-end binding strength may
contribute to smooth muscle tropomyosin’s positional
fidelity on actin (19) and explain its precise localization on
reconstituted thin filaments. In fact, structural studies suggest
that cardiac tropomyosin localization is less well defined on
actin in the absence of troponin than is smooth muscle tropo-
myosin (19).
We previously showed that aa-striated muscle tropomy-
osin is a gradually curved, semi-rigid molecule with a rela-
tively high persistence length (20,21). In the work presented
here, we studied electron microscopy (EM) images of the
smooth muscle ab-isoform of tropomyosin to assess the
end-to-end interaction and persistence length of these mole-
cules. We show that, like striated muscle tropomyosins, the
smooth muscle tropomyosin molecules are also smoothly
curved, without any obvious signs of kinking or extra
bending. We find that although the persistence length of
the smooth muscle tropomyosin is about the same as that
of the aa-striated muscle tropomyosin, the end-to-end
linkage responsible for smooth muscle tropomyosin poly-
merization is considerably stiffer. The stiffer end-to-end
association presumably allows the smooth muscle tropomy-
osin to behave mechanically as a continuous rod, despite the
lack of TnT reinforcement, and thus assists in ensuring
effective polymeric associations with F-actin in smooth
muscles cells. Our results thus provide new insights into
the assembly and function of the smooth thin filaments.MATERIALS AND METHODS
Electron microscopy and image analysis
Samples of bovine cardiac tropomyosin (>90% aa-isoform) and chicken
gizzard smooth muscle tropomyosin (an ab-heterodimer) were purified
according to Tobacman and Adelstein (22) and Jancso´ and Graceffa (23),
and rotary-shadowed (24,25) using the following procedure: Samples
diluted to 1.0 mM in a solution consisting of 5 mM Tris (pH 7.0), 5 mM
KCl, 2 mMMgCl2, 2 mMDTT, and 30% glycerol were sprayed onto freshly
cleaved mica (some samples contained 100 mM KCl to test the effects of
higher ionic strength). The proteins were allowed to dry for ~10–20 min
and then placed in an Edward’s vacuum evaporator (BOC Edwards, Wil-
mington, MA) to achieve a vacuum lower than 5  106 Torr (glycerol
was typically included in the preparations to prevent drying artifacts during
evacuation (26–28)). A total of 9 mg of platinum was evaporated over
a 1 min period from a distance of 9.5 cm at a 9 angle onto the rotating
samples, and thin carbon was then deposited over the platinum replica.
The carbon-supported platinum replica was floated off the mica onto water
and adsorbed onto 400 mesh copper grids. EM was carried out on the shad-
owed molecules with the use of a Philips CM120 electron microscope (FEI,
Hillsboro, OR) at 120 kV, and images were digitized at 28,000 magnifica-
tion with a 2Kx2K F224HD slow-scan CCD camera (TVIPS, Gauting,
Germany). The recorded images of tropomyosin were then skeletonized after
manual selection of 0.5 0.5 nm points every 4–5 nm along the center of the
protein’s longitudinal axis (20,21). The persistence length, x, was calculatedusing the tangent angle correlation method, after q (the deviation angles
along tropomyosin from an idealized straight rod) was determined for
segment lengths between 50 and 250 nm. Previously developed algorithms
specifically tailored to determine x and q (20,21) were used. Plots relating the
inverse slope of hln(cos q)i to the segment length yielded the persistence
length values, where the factor of 2 in hcosðqðsÞÞi ¼ es=2x accounts for
the two-dimensionality of the images (20,21).Molecular-dynamics simulation
A molecular-dynamics (MD) simulation was run on a homology model of
ab-chicken gizzard tropomyosin that had been constructed to match the
structure of a previously determined atomic model of aa-cardiac tropomy-
osin (20). Each amino acid residue in the first of the two a-helices of the
cardiac tropomyosin template was replaced by a corresponding residue in
the a-chain of the chicken gizzard tropomyosin sequence (18), and then
the second helix in the coiled-coil was constructed analogously from the
gizzard b-chain. The starting structure was energy-optimized and the MD
simulation was run for 35 ns at 300 K with Langevin dynamics and an
implicit solvent model using the program CHARMM c33b2 (29) as
described previously (20). The apparent persistence length, xa, was deter-
mined via tangent correlation analysis from q (deviation angles of individual
MD conformers from an idealized straight rod), and the dynamic persistence
length xd was calculated from d (deviation angles of individual conformers
from the average longitudinal trajectory of all conformers over the produc-
tion run) as detailed in previous studies (20,21). Methods to determine xd
from low-resolution, two-dimensional projections of curved rods, such as
tropomyosin in EM images, have not been described.RESULTS AND DISCUSSION
Electron microscopy
EM of rotary-shadowed tropomyosin samples is an ideal
method to reveal the outlines of elongated molecules such
as tropomyosin at ~4–5 nm resolution (24–28). In contrast
to negative staining of single molecules (20), which presents
difficulties in controlling grid surface properties and stain
thickness, rotary shadowing provides consistently reliable
results. In this study, platinum shadowing and EM were
performed to capture images of purified cardiac aa-tropomy-
osin and gizzard smooth muscle ab-tropomyosin. The single
coiled-coil molecules thus observed are referred to here as
monomers, and end-to-end linked molecules as dimers,
trimers, or polymers. EM shows that cardiac tropomyosin
(and skeletal tropomyosin; not shown) consists primarily
of 40 nm long monomers, with some occasional dimers
and short oligomers (~15% of cases). Conversely, EM shows
smooth muscle tropomyosin to be a mixture of variable-
length polymeric chains of end-to-end linked molecules
found together with fewer single molecules, dimers, and
short oligomers (~65% of the particles observed are oligo-
meric or polymeric; Fig. 1, Table 1). In all cases, both the
well-separated single molecules and the end-to-end polymers
show smoothly curved profiles and lack obvious signs of
kinks or joints (Fig. 1). No extremely bent monomers or
jointed molecular chains are seen. This suggests that tropo-
myosin molecules remain intact and relatively rigid even
after they are adsorbed and dried onto a mica substrate before
platinum shadowing is performed.Biophysical Journal 99(3) 862–868
FIGURE 1 EM of isolated tropomyosin mole-
cules. (a and b) Rotary-shadowed bovine cardiac
tropomyosin molecules. (c) Rotary-shadowed car-
diac tropomyosin complexed with TnT. (d and e)
Chicken gizzard smooth muscle tropomyosin mole-
cules. (a and d) Survey fields showing monomers
(single arrows), dimers (double arrows), and
polymers (open arrows). (b, c, and e) Montages
showing examples of monomers, dimers, and poly-
mers. (b) Top row: cardiac tropomyosin monomers;
bottom two rows: dimers. (c) Top row: cardiac
tropomyosin monomers complexed with TnT;
bottom row: dimers with TnT (arrow indicates
possible contribution of TnT at the center region
of the dimers). (e) Top row: gizzard tropomyosin
monomers; middle two rows: dimers; bottom row:
polymers. Scale bar: 100 nm for each set of images.
Molecules were examined from two or more
different protein preparations each.
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monomers
To quantify the flexibility of tropomyosin, the apparent
persistence length of shadowed tropomyosin molecules
was determined. The persistence length is a measure of a
rod’s deviations from a straight reference of similar dimen-
sions, and was ascertained here after >100 images of cardiac
and smooth muscle tropomyosin monomers were skeleton-
ized (20). The 102 nm value for the persistence length of
cardiac tropomyosin (Table 2) obtained by the tangent
correlation method (see Materials and Methods) is almost
identical to the 104 nm value obtained previously for the
aa-tropomyosin isoform preserved in negative stain (20).
The 107 nm persistence length measured for shadowed
images of smooth muscle tropomyosin monomers is also
virtually the same as these values (Table 2). Within the preci-
sion of our methods, changing the monovalent ion concen-
tration from 5 mM to 100 mM KCl in the buffer used to
suspend tropomyosin had no effect on the persistence length
of tropomyosin. A comparison of the contour length of theTABLE 1 Polymer length distribution of cardiac and smooth
muscle tropomyosin
Tropomyosin type Monomers Dimers Trimers Multimers
Cardiac muscle 476 80 16 2
Smooth muscle 242 111 45 41
Frequency of monomers, dimers, trimers, and longer polymers found in EM
samples of cardiac and smooth muscle tropomyosin.
Biophysical Journal 99(3) 862–868tropomyosin monomers (i.e., the full distance measured
along their curved profiles) with their end-to-end length
(i.e., the shortest distance measured between their two
ends) provides an estimate of molecular bending. On
average, this ratio is 1.042 and 1.041 for the cardiac and
smooth muscle tropomyosin monomers present in the
EMs. This remarkable similarity suggests that the two mono-
mer species exhibit closely matching average contours and
flexibility.Persistence length evaluation of the tropomyosin
dimers
Determining the persistence length over both the coiled-coil
section of tropomyosin and the intervening end-to-end junc-
tions should provide pertinent clues about the mechanics of
tropomyosin polymers. Indeed, end-to-end linked tropomy-
osin dimers have the simplest unit dimensions needed to
assess the regional differences that then characterize tropo-
myosin filaments. Even though much of shadowed cardiac
tropomyosin is monomeric, cardiac dimers are observed
with sufficient frequency for such an analysis to be carried
out. In addition, a corresponding assessment of smooth
muscle tropomyosin dimers found among longer polymers
can also be made.
We analyzed and compared 25 nm stretches over the distal
end section of dimeric tropomyosin and over the central
region of the dimers (i.e., where the respective coiled-coiled
structure and end-to-end links lie). When tropomyosin was
TABLE 2 Mechanical properties of cardiac and smooth
muscle tropomyosins
Tropomyosin samples





Cardiac muscle monomersz 109 102 nm –
Smooth muscle monomersx 159 107 nm –
Cardiac muscle dimers (distal parts) 132 108 nm 27.4
Cardiac muscle dimers (central part) 66 63 nm 35.9
Cardiac muscle dimers þ TnT1
(distal parts){
144 98 nm 28.9
Cardiac muscle dimers þ TnT1
(central part){
72 106 nm 27.8
Smooth muscle dimers (distal parts)k 136 107 nm 27.6
Smooth muscle dimers (central part)k 68 123 nm 25.7
*Number of molecules or segments analyzed.
yThe average end-to-end bending angle over 25 nm arc length segments was
calculated from the persistence lengths using the equation x¼ arc length/
hqi2, and confirmed by measuring and averaging the differences in angular
orientation between the two ends of each segment, as in Li et al. (20).
zxa for MD conformers is 101 nm (20).
xxa for MD conformers is 104 nm.
{An expressed TnT1 fragment representing the N-terminal 153 residues
of cardiac TnT, prepared by Hinkle et al. (41), was added to cardiac
tropomyosin at a 3:1 molar ratio to ensure complex formation at the low
concentrations used for EM studies. The tropomyosin-TnT complex was
then rotary-shadowed and the distal and central parts of 80 nm long
complexes (i.e., tropomyosin dimers with associated TnT1) were analyzed.
kThe values noted are for tropomyosin samples suspended in a solution con-
taining 5 mM KCl; raising KCl to 100 mM had a minimal effect on the
persistence length of the distal or central parts of the dimers (x ¼ 95 nm
and 114 nm at 100 mM KCl, respectively). Comparable trials in which
the salt concentration of cardiac tropomyosin was increased were not
practical, since relatively few dimers were then noted.
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the 63 nm persistence length found over the 25 nm central
region stretches of cardiac tropomyosin is considerably
lower than the 108 nm value determined for the distal regions
of the cardiac dimers, whereas the latter value is comparable
to that of monomeric tropomyosin. As expected, the persis-
tence length of the central region of the cardiac dimers
increases to that of the rest of the molecule when the tropo-
myosin is in a complex with and buttressed by the TnT1 frag-
ment of TnT (Table 2, Fig. 2 a). In marked contrast, thepersistence lengths of the ends and the central region of
the smooth muscle dimers are about the same, despite the
absence of troponin or any other accessory proteins. If
anything, the persistence length over the central region con-
taining the end-to-end association is greater (123 nm), not
smaller, than any of the other stretches examined, as would
be likely if the smooth muscle tropomyosin linkage were
particularly stiff (Table 2, Fig. 2 b). This strong end-to-end
association is minimally affected by an increase in the mono-
valent ion concentration of the tropomyosin buffer (Table 2),
suggesting that, once formed, end-to-end linkages are rela-
tively stable in the different buffers (e.g., the persistence
length for the central region of smooth muscle tropomyosin
is 123 nm at 5 mM KCl and 114 nm at 100 mM KCl).
Our data indicate that the overlap region of cardiac tropo-
myosin, which includes the end-to-end joint, is relatively
flexible unless it is supported by TnT, whereas this region
in smooth muscle tropomyosin is comparatively rigid.
Examining differences in the bending angle, q, over the
respective 25 nm arc lengths of each distal or central dimer
segment (20,21) offers an alternative approach to assess rela-
tive flexibility. The set of q angles calculated either from the
persistence length values or by direct measurement (Table 2)
indicates that on average, the central end-to-end linked
region of the cardiac dimers bends more than any of the other
zones tested and therefore is likely to be the most flexible.Reliability of persistence length data
As a means of determining tropomyosin flexibility, we calcu-
late the persistence length values to quantify the bending
variance of tropomyosin. However, measurement error,
such as in determining the centerline of tropomyosin mole-
cules during skeletonization, can introduce an extra variance
that is unrelated to tropomyosin bending and its persistence
length. The inherent variation in tropomyosin bending,
however, appears to greatly outweigh the variance due to
experimental error. In fact, the persistence length values
determined from cardiac tropomyosin monomers preserved
by two different techniques (rotary shadowing and negative
staining) are virtually the same (102 and 104 nm), and thusFIGURE 2 Apparent persistence length mea-
surements of rotary-shadowed tropomyosin dimers.
The tangent correlation method used to calculate
the persistence length (x) plots ln hcos qi as a func-
tion of arc length along tropomyosin (where q is the
deviation angle from a straight rod); the inverse
slope of the regression line yields 2x. Persistence
length measurements of (a) cardiac and (b) smooth
muscle tropomyosin; (A) plots for 25 nm distal
end (labeled ends) sections of tropomyosin; (x)
plots for 25 nm central (labeled middle) sections
of tropomyosin. Regression lines through the
respective points are represented by tick marks.
The tangent angles determined for the arc lengths
measured were normally distributed.
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866 Sousa et al.methodological error is unlikely. Moreover, when images of
tropomyosin are sorted into half data sets (e.g., represented
by randomly chosen 25 nm stretches at opposite ends of
tropomyosin dimers), comparable persistence length values
for each half data set are obtained (110 nm and 106 nm for
cardiac, 101 nm and 109 nm for smooth muscle), again
suggesting that the measurement errors are small. Lastly,
the MD simulation of smooth muscle tropomyosin per-
formed here (and of cardiac tropomyosin performed previ-
ously (20)), which is not subject to experimental errors
encountered with isolated proteins, provides a completely
independent means of characterizing the flexural movement
of tropomyosin monomers. Conspicuously, MD conformers
of smooth muscle tropomyosin display a persistence length
(104 nm) that is the same as values reported above and those
in the MD characterization of cardiac tropomyosin (101 nm
(20,21)).CONCLUSIONS
Monomeric tropomyosin binds to actin filaments with
exceedingly low affinity (16,17). The protein only binds
actin effectively as a member of narrow polymeric filaments
once the protein self-associates end-to-end. The collective
electrostatic interactions between tropomyosin filaments
and the surface of actin are then appreciable (16). Thus,
thin filaments can be best thought of as a composite structure
consisting of semiautonomous actin and tropomyosin fila-
ments, though each component filament is further subject
to the influence of troponin, myosin, and other actin-binding
proteins. It is therefore not surprising that altered tropomy-
osin molecules that are incapable of forming end-to-end
links cannot associate appreciably with F-actin (30–34).
However, once assembled, the tropomyosin filament must
be rigid enough to act as a gatekeeper on the thin filaments,
thereby governing the access of actin-binding proteins. In
contrast, if tropomyosin were very flexible, the gatekeeping
function would fail, since actin-binding proteins would
inappropriately displace the tropomyosin. Considerable
tropomyosin stiffness is also necessary to ensure the effec-
tive cooperative movement of tropomyosin over actin in
response to myosin cross-bridge binding. Alternatively, if
tropomyosin were very flexible, cooperativity would be
dampened. In fact, as shown here and in previous studies
(20,21), the coiled-coil of tropomyosin is semi-rigid, with
an overall apparent persistence length of ~100 nm.
The ~100 nm apparent persistence length values measured
actually underestimate the rigidity of cardiac tropomyosin
monomers by a factor of 4–5, since the inherent curvature
of the tropomyosin (comprising the so-called intrinsic persis-
tence length) must be taken into account to determine the
dynamic persistence length, a truer measure of flexural
rigidity (20,21). MD simulations of tropomyosin offer a
means of separating the components of persistence length
(20,21) and identifying the dynamic component. An analysisBiophysical Journal 99(3) 862–868of conformers of smooth muscle tropomyosin taken during
the MD simulations performed here shows a trend identical
to that found previously for cardiac tropomyosin, i.e., a
104 nm apparent persistence length translates into a 343 nm
dynamic persistence length. Hence, EM and MD show that
the parameters that describe the flexural stiffness along the
coiled-coil structure of both smooth and cardiac tropomyosin
are essentially the same.
Although previous studies have shown that isolated tropo-
myosin molecules behave like semi-rigid rods (20,21), little
information is available about the mechanics of the end-to-
end linkage within tropomyosin polymers. This deficit is
unfortunate, since after all, tropomyosin functions on actin
as a polymeric filament and not in isolation. Early works
in which striated and smooth muscle tropomyosins were
characterized by viscometry and analytical ultracentrifuga-
tion indicated that smooth muscle tropomyosin may form
more stable polymers, resulting in stronger end-to-end
interactions compared to those induced by striated muscle
isoforms (18,35–37). It should be noted, however, that
hydrodynamic tools assess polymerization indirectly, and
the corresponding conclusions reached, although compel-
ling, are subject to alternative explanations. For example,
the methods do not necessarily distinguish among the effects
of tropomyosin chain length, flexibility, and side-to-side
interactions. In this study, we examined and compared the
polymerization levels and end-to-end stiffness of smooth
and cardiac muscle tropomyosin directly. Indeed, our EM
results show a higher propensity of the smooth muscle tropo-
myosin to polymerize, confirming the earlier inferences. This
raises the interesting possibility that preformed smooth
muscle (and perhaps nonmuscle) tropomyosin polymers
may provide a scaffold for F-actin polymerization and
assembly in vivo. Accordingly, in some cases, tropomyosin
may serve as a nucleation factor for new actin filament
formation. Given the abundance of tropomyosin isoforms
in cells, such tropomyosin polymers may be responsible
for localizing the assembly of actin filaments in specific
cytoskeletal compartments, as proposed by the Gunning
group (1,2).
Our evaluation of persistence lengths indicates that the
rigidity of smooth muscle tropomyosin is undiminished
over their end-to-end linkages, and thus smooth muscle
tropomyosin appears to be capable of acting as continuous
semi-rigid strands despite the lack of troponin. In marked
contrast, striated muscle tropomyosin is relatively flexible
over its end-to-end linkage, but in vivo is likely to be
strengthened mechanically by troponin, consistent with
results reported here for the effect of TnT1 on cardiac tropo-
myosin. Considerable sequence variation occurs at the
C-terminal ends of the respective isoforms (18,36), which
may account for different end-to-end interactions and associ-
ations with other ligands (38). To gain an explicit under-
standing of the mechanical and functional differences
between tropomyosin isoforms, it is necessary to relate the
Smooth Muscle Tropomyosin Is Semi-Rigid 867high-resolution structures of end-to-end tropomyosin junc-
tions to each other.
Our goal is to develop definitive structural models of
tropomyosin’s regulatory movements on actin to determine
the basis of the thin filament’s cooperative unit size and
behavior. We have shown here that tropomyosin monomers
and polymerized tropomyosin strands have quite stiff mate-
rial properties, consistent with their cooperative behavior on
actin. However, a full description of the energy landscape
between tropomyosin and actin that constrains the move-
ment of semi-rigid tropomyosin on F-actin is still lacking.
Hence, the effective persistence length of tropomyosin on
thin filaments, and the influence of myosin and (in the case
of striated muscle) troponin on cooperative movement
cannot be meaningfully modeled based on the data collected
here. The effects of caldesmon on stiffening of tropomyosin
in smooth muscle thin filaments, and the influence of calcium
on the stiffening effect of troponin in striated muscle thin
filaments, as observed here in the absence of actin, also
remain to be determined. Thus, despite work by others
suggesting tissue-specific differences in thin-filament coop-
erative unit size in intact systems (39,40), it is premature to
speculate about the corresponding underpinnings of tropo-
myosin’s structural dynamics on thin filaments, however
stiff the tropomyosin strands are, without an adequate repre-
sentation of the interface between the two proteins. Although
considerable accomplishments in elucidating the structural
mechanics of tropomyosins have been achieved, the chal-
lenge remains to develop and characterize atomic models
of F-actin tropomyosin.Note added in proof: The persistence lengths derived from molecular
dynamics simulations of chicken gizzard tropomyosin were mistakenly
reported for the aa-isoform and not the ab-isoform as intended; the values
for the two are virtually the same. The apparent persistence length values of
ab-gizzard tropomyosin range between 110 and 120 nm during a 15 ns
simulation.
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